SCHEMBL1942057

SCHEMBL1942057

COc1ccc2c(OC3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5CCCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)N4C3)cc(-c3ccccc3)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.55
▸ ADRB3 P13945 1/20 0.41
▸ ADRA2B P18089 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ CYP3A4 P08684 3/20 0.38
▸ CTSS P25774 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ ACACB O00763 1/20 0.32
▸ TACR3 P29371 2/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ MITF O75030 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ PAX8 Q06710 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1940779 1.00 CTSB (0.55) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL1942948 1.00 CTSB (0.55) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL1942687 1.00 CTSB (0.55) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL1942507 0.98 CTSB (0.53) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL1942391 0.98 CTSB (0.53) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL6369432 0.94 CTSB (0.57) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL6800080 0.94 CTSB (0.57) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL6804142 0.94 CTSB (0.58) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL6797924 0.94 CTSB (0.58) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL1941151 0.93 CTSB (0.54) CTSBADRB3ADRA2BADRA2CCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455809-B1 INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-06-15 — — EP disclosed
US-6867185-B2 Inhibitors of hepatitis C virus BRISTOL-MYERS SQUIBB COMPANY (US) 2005-03-15 — — US disclosed
Send feedback